(Incorporated in the Cayman Islands) We are a newly established blank check company. We intend to leverage our network and experience to acquire undervalued professional sports franchises and related platforms that can benefit from institutional capital, modernized governance, and operational efficiencies. Although not limited to any geography, the initial focus is on the European sports market, […]

Note: This is NOT an IPO. This is a NASDAQ Direct Listing. AMASS Brands has registered to sell up to 12.4 million shares in the Direct Listing. Existing shareholders will sell stock in the Direct Listing. No new stock is being issued, according to the prospectus. We run a portfolio of premium beverage brands with […]

(Incorporated in Delaware) We are a pioneer in fully adaptive and cognitive mission-level autonomous robotics and artificial intelligence (“AI”), delivering advanced solutions that enable safe, efficient, and scalable autonomy in complex, GPS-denied environments. Our mission is to deliver world-class autonomous robots to data-hungry industries to unlock new insights that drive smarter decisions. Leveraging proprietary Level 4B […]

Note: This company has no affiliation with Elon Musk’s company, Starlink. (Incorporated in Delaware) We are a newly organized blank check company. We intend to target businesses in the Americas, Europe and Asia. Gus Liu is our CEO and a director of our company. He is also the CEO of WeSoul Labs. After the IPO, […]

(Incorporated in the Cayman Islands) We are a newly organized blank check company. We may pursue an initial business combination in any business or industry, but expect to target opportunities and companies that are in the climate transition, specialty finance, renewable energy, and regenerative agriculture sectors. (Note: Energy Transition Special Opportunities Fund priced its SPAC […]

(Incorporated in Delaware) We are a Phase 2 biopharmaceutical company developing continuous delivery technology for existing FDA-approved cancer treatments. Our lead program, STAR-LLD, targets multiple myeloma and chronic lymphocytic leukemia. We are investigating the potential of combining STAR-LLD with CAR-T therapies and extending our work to include other types of cancer such as B-cell lymphomas […]

Note: This is NOT an IPO. This is a NASDAQ Direct Listing. We do not intend to raise new capital. (Incorporated in Delaware) We intend to use our licensed proprietary AI to establish an AI-driven ecosystem. M2, an investment firm founded by John Rochon, our chairman, is providing the licensed proprietary AI. We plan to […]

(Incorporated in Delaware) We are a clinical-stage biopharmaceutical company pioneering inhaled therapies to transform the treatment paradigm of serious, rare respiratory diseases with significant unmet needs. Our approach is designed to address the limitations of current oral therapies by delivering optimized inhaled formulations of approved oral medicines directly to the lungs to enhance efficacy and […]

(Incorporated in Delaware) We are building an AI Agent Operating System for enterprise workflow automation for modern businesses.  Note: Net loss and revenue are in U.S. dollars for the fiscal year that ended Dec. 31, 2025. (Note: VIDA Global upsized its small IPO at pricing to 3.75 million shares and priced the IPO at $4.00 […]

(Incorporated in the British Virgin Islands) We are the sixth blank check company organized by Suying Liu under the Mountain Crest affiliation. We intend to focus our search for an acquisition target on businesses in North America and the Asia Pacific region. While there is no restriction or limitation on what industry or geographic region […]